Jazz Pharmaceuticals plc (JAZZ) insider trading

By person

36 insiders · 485 transactions

32.2×

Renee D. Gala holds 32.2 times base salary in stock. $32.32M of shares against $1.00M in salary for 2025.

Salary from the company's own proxy. The shares are what Renee D. Gala last reported holding, valued at $225.37, the price Ordinary Shares was last bought or sold at on the open market here, on 3 Nov 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Bruce C Cozadd

Director

—

$72.62M (135) scheduled

−$72.62M

339,875

0.5236%

$76.60M

+17.7%

Seamus Mulligan

Director

$22.77M (13)

—

+$22.77M

1,286,254

1.98%

$289.88M

+22.7%

Robert Iannone

EVP, Global Head of R&D & CMO

—

$22.01M (11) scheduled

−$22.01M

65,686

0.1012%

$14.80M

+4,629%

Neena M Patil

EVP & Chief Legal Officer

—

$14.28M (24) scheduled

−$14.28M

47,671

0.0734%

$10.74M

+3,726%

Patrick G Enright

Director

—

$6.41M (21)

−$6.41M

21,278

0.0328%

$4.80M

+25.0%

Rick E Winningham

Director

—

$6.18M (14) scheduled

−$6.18M

9,466

0.0146%

$2.13M

−30.8%

Patricia Carr

SVP, Chief Accounting Officer

—

$5.83M (44) scheduled

−$5.83M

6,512

0.0100%

$1.47M

+17.0%

Samantha Pearce

EVP, Chief Commercial Officer

—

$4.92M (12) scheduled

−$4.92M

47,131

0.0726%

$10.62M

+5,806%

Suzanne Sawochka Hooper

EVP & General Counsel

—

$4.24M (8)

−$4.24M

39,738

0.0612%

$8.96M

+6.7%

Kenneth W O'Keefe

Director

$227.69K (3)

$4.03M (14)

−$3.80M

30,256

0.0466%

$6.82M

+207.2%

Karen J Wilson

SVP, Finance & PAO

—

$3.17M (6) scheduled

−$3.17M

18,385

0.0283%

$4.14M

+6.6%

Matthew P. Young

EVP & CFO

—

$3.14M (23)

−$3.14M

36,200

0.0558%

$8.16M

+6.0%

Heather Ann McSharry

Director

—

$2.98M (11) scheduled

−$2.98M

18,199

0.0280%

$4.10M

+199.5%

Catherine A. Sohn

Director

—

$2.88M (10) scheduled

−$2.88M

14,868

0.0229%

$3.35M

+143.1%

Norbert G Riedel

Director

—

$2.86M (10) scheduled

−$2.86M

17,553

0.0270%

$3.96M

+254.4%

Renee D Gala

President & CEO

—

$2.40M (5)

−$2.40M

140,394

0.2163%

$31.64M

+9,871%

Peter Gray

Director

—

$2.16M (8) scheduled

−$2.16M

16,068

0.0248%

$3.62M

+137.9%

Paul Treacy

SVP, Technical Operations

—

$1.61M (13)

−$1.61M

16,418

0.0253%

$3.70M

+12.5%

Mary Elizabeth Henderson

SVP, Technical Operations

—

$1.57M (3)

−$1.57M

23,815

0.0367%

$5.37M

—

Michael Patrick Miller

EVP, US Commercial

—

$1.46M (26)

−$1.46M

22,118

0.0341%

$4.98M

+23.2%

Philip L Johnson

EVP & Chief Financial Officer

$1.44M (1)

—

+$1.44M

56,431

0.0869%

$12.72M

+8,745%

Kim Sablich

EVP, GM of U.S.

—

$1.37M (9)

−$1.37M

28,478

0.0439%

$6.42M

—

Paul L Berns

Director

—

$1.36M (9)

−$1.36M

8,290

0.0128%

$1.87M

+58.4%

Finbar Larkin

SVP, Technical Operations

—

$1.29M (13)

−$1.29M

21,779

0.0336%

$4.91M

+126.1%

Iain McGill

SVP, Europe & Rest of World

—

$1.07M (1) scheduled

−$1.07M

24,938

0.0384%

$5.62M

+35.4%

Christopher J. Tovey

EVP, COO & Managing Director E

—

$833.44K (2) scheduled

−$833.44K

14,663

0.0226%

$3.30M

+58,552%

Mark Douglas Smith

Director

—

$769.36K (6)

−$769.36K

9,579

0.0148%

$2.16M

—

Elmar Schnee

Director

—

$663.90K (6)

−$663.90K

8,270

0.0127%

$1.86M

+59.8%

Russell J. Cox

EVP & COO

—

$515.00K (2)

−$515.00K

102,821

0.1584%

$23.17M

+100.3%

Jennifer E. Cook

Director

—

$502.62K (5)

−$502.62K

10,736

0.0165%

$2.42M

—

Anne ORiordan

Director

—

$406.74K (4)

−$406.74K

16,500

0.0254%

$3.72M

—

Daniel N Swisher JR

President and COO

—

55,014

0.0847%

$12.40M

+5,778%

Karen L. Smith

EVP, R&D and CMO

—

28,474

0.0439%

$6.42M

+98.3%

Laura Hamill

Director

—

6,832

0.0105%

$1.54M

+355.5%

Patrick Kennedy

Director

—

6,452

0.0099%

$1.45M

—

Ted W Love

Director

—

2,389

0.0037%

$538.41K

—

Jazz Pharmaceuticals plc

What the insiders did Net selling

By person